Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

List/tripsitting: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>David Hedlund
CBD heated to 250-300 C will partially be converted to THC. - pmid=33903673
>David Hedlund
{{Risks with inhaled CBD}}
Line 120: Line 120:
                 <li class="featured list-item">
                 <li class="featured list-item">
<h4 class="media-heading">[[Cannabinoid antidotes|Antidotes]]</h4>
<h4 class="media-heading">[[Cannabinoid antidotes|Antidotes]]</h4>
*[[CBD]] (''non-inhalant ROA'')
*[[CBD]] (''non-inhalant ROA''):
** CBD heated to 250-300 C will partially be converted to THC.<ref>{{cite journal |last1=Czégény |first1=Z |last2=Nagy |first2=G |last3=Babinszki |first3=B |last4=Bajtel |first4=Á |last5=Sebestyén |first5=Z |last6=Kiss |first6=T |last7=Csupor-Löffler |first7=B |last8=Tóth |first8=B |last9=Csupor |first9=D |title=CBD, a precursor of THC in e-cigarettes. |journal=Scientific reports |date=26 April 2021 |volume=11 |issue=1 |pages=8951 |doi=10.1038/s41598-021-88389-z |pmid=33903673 |pmc=8076212}}</ref>
{{Risks with inhaled CBD}}
** CBD:THC ratio: 50:1<ref>{{cite journal | vauthors=((Englund, A.)), ((Oliver, D.)), ((Chesney, E.)), ((Chester, L.)), ((Wilson, J.)), ((Sovi, S.)), ((De Micheli, A.)), ((Hodsoll, J.)), ((Fusar-Poli, P.)), ((Strang, J.)), ((Murray, R. M.)), ((Freeman, T. P.)), ((McGuire, P.)) | journal=Neuropsychopharmacology | title=Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios | pages=1–8 | date=16 November 2022 | url=https://www.nature.com/articles/s41386-022-01478-z | issn=1740-634X | doi=10.1038/s41386-022-01478-z | access-date=25 November 2022}}</ref>
                 </li>
                 </li>
             </ul>
             </ul>

Revision as of 06:03, 23 December 2022



Cannabinoid tripsitting

Miscellaneous hallucinogen tripsitting

  1. Czégény, Z; Nagy, G; Babinszki, B; Bajtel, Á; Sebestyén, Z; Kiss, T; Csupor-Löffler, B; Tóth, B; Csupor, D (26 April 2021). "CBD, a precursor of THC in e-cigarettes". Scientific reports. 11 (1): 8951. doi:10.1038/s41598-021-88389-z. PMID 33903673. 
  2. Englund, A., Oliver, D., Chesney, E., Chester, L., Wilson, J., Sovi, S., De Micheli, A., Hodsoll, J., Fusar-Poli, P., Strang, J., Murray, R. M., Freeman, T. P., McGuire, P. (16 November 2022). "Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios". Neuropsychopharmacology: 1–8. doi:10.1038/s41386-022-01478-z. ISSN 1740-634X. Retrieved 25 November 2022.